Journal
JOURNAL OF NATURAL PRODUCTS
Volume 79, Issue 4, Pages 894-898Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jnatprod.5b00950
Keywords
-
Funding
- Alexander von Humboldt Foundation
- ASAFEM Project under ERAfrica Programme [IC-070]
- German Academic Exchange Service (DAAD)
- Kenya National Council of Science, Technology and Innovation (NACOSTI)
Ask authors/readers for more resources
Bioassay-guided fractionation of the mycelial extract of a basidiomycete culture collected in Kenya led to the isolation of two new cyathane diterpenoids named laxitextines A (1) and B (2). The producer strain was characterized by detailed taxonomic studies based on rDNA using the 5.8S gene region, the internal transcribed spacer 2 (ITS2), and part of the large subunit that identified the fungus as Laxitextum incrustatum. The structures of 1 and 2 were elucidated by NMR spectroscopic and mass spectrometric analyses. Both compounds exhibited moderate activities against Gram-positive bacteria Bacillus subtilis (DSM 10), Staphylococcus aureus (DSM 346), and methicillin-resistant Staph. aureus (DSM 1182). The two compounds also showed variable antiproliferative activities against mouse fibroblast (L929) and selected human cell lines (breast cancer MCF-7, epidermoid carcinoma A431, and umbilical vein endothelial HUVEC). The IC50 values with respect to the MCF-7 cell line for compounds 1 and 2 were 2.3 and 2.0 mu M, respectively.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available